clinical trials

May 6, 2021 | Maryam Shahzad

Novavax Initiates COVID-19 Vaccine Trials for Adolescents

Vaccine development company Novavax, headquartered in Gaithersburg, announced Monday that it expanded Phase 3 clinical trials for its COVID-19 vaccine candidate to include adolescents. The trials will include up to 3,000 youths ages 12-17 at up to 75 sites in the U.S., the company said in a press release. “Through the expansion of our PREVENT-19 […]

Read more

February 19, 2021 | Maryam Shahzad

Altimmune Announces FDA Approval for Phase 1 COVID-19 Vaccine Clinical Trials 

Altimmune, Inc. announced Wednesday that it was approved by the FDA to begin Phase 1 clinical trials for AdCOVID, its single-dose nasal spray COVID-19 vaccine candidate. The clinical stage biopharmaceutical company, headquartered in Gaithersburg, expects to begin volunteer enrollment in the trials in the coming week, according to a statement from the company. “We believe […]

Read more

December 16, 2020 | Maryam Shahzad

State Officials Explain What’s in Pfizer’s COVID-19 Vaccine

What’s in Pfizer’s COVID-19 vaccine? Dr. David Marcozzi, COVID-19 Incident Commander for the University of Maryland Medical System, explained the answer to Marylanders at a press conference with Gov. Larry Hogan on Tuesday. Pfizer’s vaccine was granted emergency use authorization (EUA) by the FDA last Friday. Marcozzi said there are four components that make it […]

Read more

August 12, 2020 | Isabel Cleary

Gaithersburg-Based Novavax Included in New York Times’ Coronavirus Vaccine Tracker

The New York Times has published a coronavirus vaccine tracker that shows the progress of the more than 165 vaccines in development, and the 30 that are in human trials. The coronavirus pandemic has forced researchers to condense years of research and testing into a shorter time frame, with the goal to produce a safe […]

Read more

May 26, 2020 | Maryam Shahzad

Gaithersburg Vaccine Development Company Testing Candidate for COVID-19

A vaccine development company headquartered in Gaithersburg is starting clinical trials for a potential COVID-19 vaccine.  Novavax will administer the trials for vaccine candidate NVX‑CoV2373 in two phases, a statement from the company says. Phase 1 will test 131 people in Australia for immune response and safety. Results are expected in July. “Administering our vaccine […]

Read more

July 21, 2016 | Phyllis Armstrong

New Jobs and Road Improvements Coming to I-270 Corridor (VIDEO)

As many as 100 new jobs will be created in Montgomery County from development of new vaccine by the Novavax company in Gaithersburg. The vaccine still in clinical trials could help prevent one of the major causes of respiratory infections in infants, children and older adults. Maryland Governor Larry Hogan made the company’s labs one of […]

Read more

November 29, 2012 | Sheila Ogilvie

Alzheimer’s Awareness Month

 Transforming Lives – National Alzheimer’s Disease Awareness Month Alzheimer’s is the sixth leading cause of death in the United States — 5.4 million Americans are living with Alzheimer’s disease and nearly 15 million are acting as caregivers.  86,000 people in Maryland are diagnosed with this devastating disease and approximately 20% of them live in Montgomery […]

Read more

Engage us on Facebook

Follow us on Twitter